vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and EXPONENT INC (EXPO). Click either name above to swap in a different company.

PATHWARD FINANCIAL, INC. is the larger business by last-quarter revenue ($276.3M vs $166.3M, roughly 1.7× EXPONENT INC). PATHWARD FINANCIAL, INC. runs the higher net margin — 26.4% vs 17.8%, a 8.6% gap on every dollar of revenue. Over the past eight quarters, PATHWARD FINANCIAL, INC.'s revenue compounded faster (21.0% CAGR vs 8.8%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.

CASH vs EXPO — Head-to-Head

Bigger by revenue
CASH
CASH
1.7× larger
CASH
$276.3M
$166.3M
EXPO
Higher net margin
CASH
CASH
8.6% more per $
CASH
26.4%
17.8%
EXPO
Faster 2-yr revenue CAGR
CASH
CASH
Annualised
CASH
21.0%
8.8%
EXPO

Income Statement — Q2 FY2026 vs Q1 FY2027

Metric
CASH
CASH
EXPO
EXPO
Revenue
$276.3M
$166.3M
Net Profit
$72.9M
$29.6M
Gross Margin
Operating Margin
24.9%
Net Margin
26.4%
17.8%
Revenue YoY
14.3%
Net Profit YoY
11.0%
EPS (diluted)
$3.35
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
EXPO
EXPO
Q1 26
$276.3M
$166.3M
Q4 25
$173.1M
$147.1M
Q3 25
$186.7M
$142.0M
Q2 25
$195.8M
$145.5M
Q1 25
$274.8M
$136.8M
Q4 24
$182.6M
Q3 24
$179.5M
$136.3M
Q2 24
$188.6M
$140.5M
Net Profit
CASH
CASH
EXPO
EXPO
Q1 26
$72.9M
$29.6M
Q4 25
$35.2M
$28.0M
Q3 25
$38.8M
$26.6M
Q2 25
$42.1M
$26.6M
Q1 25
$75.0M
$23.6M
Q4 24
$30.0M
Q3 24
$33.5M
$26.0M
Q2 24
$44.9M
$29.2M
Operating Margin
CASH
CASH
EXPO
EXPO
Q1 26
24.9%
Q4 25
24.6%
19.7%
Q3 25
25.9%
12.1%
Q2 25
24.1%
30.5%
Q1 25
33.2%
19.9%
Q4 24
19.8%
Q3 24
20.9%
19.0%
Q2 24
27.1%
25.4%
Net Margin
CASH
CASH
EXPO
EXPO
Q1 26
26.4%
17.8%
Q4 25
20.3%
19.1%
Q3 25
20.8%
18.7%
Q2 25
21.5%
18.3%
Q1 25
27.3%
17.2%
Q4 24
16.4%
Q3 24
18.7%
19.1%
Q2 24
23.8%
20.8%
EPS (diluted)
CASH
CASH
EXPO
EXPO
Q1 26
$3.35
$0.59
Q4 25
$1.57
$0.55
Q3 25
$1.69
$0.52
Q2 25
$1.81
$0.52
Q1 25
$3.14
$0.45
Q4 24
$1.23
Q3 24
$1.34
$0.50
Q2 24
$1.78
$0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
EXPO
EXPO
Cash + ST InvestmentsLiquidity on hand
$157.6M
$118.6M
Total DebtLower is stronger
$59.5M
Stockholders' EquityBook value
$850.7M
$338.3M
Total Assets
$7.1B
$687.4M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
EXPO
EXPO
Q1 26
$157.6M
$118.6M
Q4 25
$331.2M
$207.4M
Q3 25
$120.6M
$231.8M
Q2 25
$258.3M
$245.1M
Q1 25
$254.2M
$258.9M
Q4 24
$597.4M
Q3 24
$158.3M
$219.7M
Q2 24
$298.9M
$203.3M
Total Debt
CASH
CASH
EXPO
EXPO
Q1 26
$59.5M
Q4 25
$33.5M
Q3 25
$33.5M
Q2 25
$33.4M
Q1 25
$33.4M
Q4 24
$33.4M
Q3 24
$33.4M
Q2 24
$33.3M
Stockholders' Equity
CASH
CASH
EXPO
EXPO
Q1 26
$850.7M
$338.3M
Q4 25
$854.5M
$402.9M
Q3 25
$858.0M
$427.8M
Q2 25
$819.0M
$441.4M
Q1 25
$814.7M
$421.1M
Q4 24
$758.3M
Q3 24
$822.5M
$410.3M
Q2 24
$748.4M
$393.2M
Total Assets
CASH
CASH
EXPO
EXPO
Q1 26
$7.1B
$687.4M
Q4 25
$7.6B
$761.4M
Q3 25
$7.2B
$759.4M
Q2 25
$7.2B
$763.2M
Q1 25
$7.0B
$777.3M
Q4 24
$7.6B
Q3 24
$7.5B
$744.1M
Q2 24
$7.5B
$709.2M
Debt / Equity
CASH
CASH
EXPO
EXPO
Q1 26
0.07×
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Noninterest Income$151.2M55%
Net Interest Income$125.1M45%

EXPO
EXPO

Revenues before reimbursements$151.8M91%
Reimbursements$14.5M9%

Related Comparisons